ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00426712
Recruitment Status : Completed
First Posted : January 25, 2007
Last Update Posted : March 1, 2018
Sponsor:
Information provided by (Responsible Party):
Dynavax Technologies Corporation

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2008
  Actual Study Completion Date : March 2008